Medical Imaging News
Subclinical Amyloid: Next Target for Alzheimer’...
"PET amyloid has historically largely been considered a positive or negative diagnostic test," McMillan told MedPage Today. "But this study suggests that quantitative measurements of PET amyloid in pre-symptomatic individuals...
Subclinical Amyloid: Next Target for Alzheimer’...
"PET amyloid has historically largely been considered a positive or negative diagnostic test," McMillan told MedPage Today. "But this study suggests that quantitative measurements of PET amyloid in pre-symptomatic individuals...
New PET imaging agent may help assess, treat br...
A new imaging agent for positron emission tomography, or PET, scans could help assess and treat people with various neurological diseases, including Alzheimer's and Parkinson's diseases and multiple sclerosis, according...
New PET imaging agent may help assess, treat br...
A new imaging agent for positron emission tomography, or PET, scans could help assess and treat people with various neurological diseases, including Alzheimer's and Parkinson's diseases and multiple sclerosis, according...
SNMMI seeks expanded coverage for NaF PET
SNMMI, the World Molecular Imaging Society (WMIS), and the American College of Radiology (ACR) are recommending that the Centers for Medicare and Medicaid Services (CMS) reconsider the current restrictive coverage...
SNMMI seeks expanded coverage for NaF PET
SNMMI, the World Molecular Imaging Society (WMIS), and the American College of Radiology (ACR) are recommending that the Centers for Medicare and Medicaid Services (CMS) reconsider the current restrictive coverage...
New PET imaging agent predicts tumor response t...
A team at the Stanford University School of Medicine developed a PET imaging agent that can predict a tumor’s response to a widely-used lung cancer drug with more than 80...
New PET imaging agent predicts tumor response t...
A team at the Stanford University School of Medicine developed a PET imaging agent that can predict a tumor’s response to a widely-used lung cancer drug with more than 80...
PSMA PET/CT Clearly Differentiates Prostate Can...
Using [PET] nuclear medicine, German researchers have found a way to accurately differentiate cancerous tissue from healthy tissue in prostate cancer patients. The research is highlighted in the February issue...
PSMA PET/CT Clearly Differentiates Prostate Can...
Using [PET] nuclear medicine, German researchers have found a way to accurately differentiate cancerous tissue from healthy tissue in prostate cancer patients. The research is highlighted in the February issue...
FDG PET/CT for Infection Imaging
18F-Fluorodeoxyglucose (FDG) PET/CT is routinely used in oncological imaging. The use of FDG imaging has also expanded beyond oncology to include cardiac viability studies, assessment of neurological diseases including dementia...
FDG PET/CT for Infection Imaging
18F-Fluorodeoxyglucose (FDG) PET/CT is routinely used in oncological imaging. The use of FDG imaging has also expanded beyond oncology to include cardiac viability studies, assessment of neurological diseases including dementia...